1003 related articles for article (PubMed ID: 29452209)
21. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress.
Liu J; Yang P; Zuo G; He S; Tan W; Zhang X; Su C; Zhao L; Wei L; Chen Y; Ruan X; Chen Y
Lipids Health Dis; 2018 Jul; 17(1):153. PubMed ID: 30016988
[TBL] [Abstract][Full Text] [Related]
22. Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients.
Enooku K; Tsutsumi T; Kondo M; Fujiwara N; Sasako T; Shibahara J; Kado A; Okushin K; Fujinaga H; Nakagomi R; Minami T; Sato M; Uchino K; Nakagawa H; Kondo Y; Asaoka Y; Tateishi R; Ueki K; Ikeda H; Yoshida H; Moriya K; Yotsuyanagi H; Kadowaki T; Koike K
J Gastroenterol; 2020 Feb; 55(2):227-243. PubMed ID: 31602526
[TBL] [Abstract][Full Text] [Related]
23. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells.
Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B
Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.
Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554
[TBL] [Abstract][Full Text] [Related]
25. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
Fu D; Cui H; Zhang Y
Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice.
Zhang ZC; Liu Y; Xiao LL; Li SF; Jiang JH; Zhao Y; Qian SW; Tang QQ; Li X
J Hepatol; 2015 Dec; 63(6):1466-75. PubMed ID: 26272872
[TBL] [Abstract][Full Text] [Related]
27. Rapamycin-mediated CD36 translational suppression contributes to alleviation of hepatic steatosis.
Wang C; Yan Y; Hu L; Zhao L; Yang P; Moorhead JF; Varghese Z; Chen Y; Ruan XZ
Biochem Biophys Res Commun; 2014 Apr; 447(1):57-63. PubMed ID: 24685479
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of long non-coding RNA Gm10804 suppresses disorders of hepatic glucose and lipid metabolism in diabetes with non-alcoholic fatty liver disease.
Li T; Huang X; Yue Z; Meng L; Hu Y
Cell Biochem Funct; 2020 Oct; 38(7):839-846. PubMed ID: 32212193
[TBL] [Abstract][Full Text] [Related]
29. CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading.
Chu X; Jin Q; Chen H; Wood GC; Petrick A; Strodel W; Gabrielsen J; Benotti P; Mirshahi T; Carey DJ; Still CD; DiStefano JK; Gerhard GS
J Transl Med; 2018 Apr; 16(1):108. PubMed ID: 29690903
[TBL] [Abstract][Full Text] [Related]
30. PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-
Liu Y; Cheng F; Luo Y; Zhan Z; Hu P; Ren H; Tang H; Peng M
Biomed Res Int; 2017; 2017():8234507. PubMed ID: 28770225
[TBL] [Abstract][Full Text] [Related]
31. Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance.
Kim HY; Park SY; Lee MH; Rho JH; Oh YJ; Jung HU; Yoo SH; Jeong NY; Lee HJ; Suh S; Seo SY; Cheong J; Jeong JS; Yoo YH
J Hepatol; 2015 Aug; 63(2):477-85. PubMed ID: 25646886
[TBL] [Abstract][Full Text] [Related]
32. Molecular characterization of prolactin receptor (cPRLR) gene in chickens: gene structure, tissue expression, promoter analysis, and its interaction with chicken prolactin (cPRL) and prolactin-like protein (cPRL-L).
Bu G; Ying Wang C; Cai G; Leung FC; Xu M; Wang H; Huang G; Li J; Wang Y
Mol Cell Endocrinol; 2013 May; 370(1-2):149-62. PubMed ID: 23499864
[TBL] [Abstract][Full Text] [Related]
33. Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.
Yuan F; Wang H; Tian Y; Li Q; He L; Li N; Liu Z
Lipids Health Dis; 2016 Feb; 15():20. PubMed ID: 26832365
[TBL] [Abstract][Full Text] [Related]
34. Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway.
Zhang C; Luo X; Chen J; Zhou B; Yang M; Liu R; Liu D; Gu HF; Zhu Z; Zheng H; Li L; Yang G
Diabetes; 2019 Oct; 68(10):1902-1914. PubMed ID: 31292134
[TBL] [Abstract][Full Text] [Related]
35. Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model.
Im AR; Kim YH; Lee HW; Song KH
J Med Food; 2016 May; 19(5):495-503. PubMed ID: 27152979
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia-inducible factor 2α drives hepatosteatosis through the fatty acid translocase CD36.
Rey E; Meléndez-Rodríguez F; Marañón P; Gil-Valle M; Carrasco AG; Torres-Capelli M; Chávez S; Del Pozo-Maroto E; Rodríguez de Cía J; Aragonés J; García-Monzón C; González-Rodríguez Á
Liver Int; 2020 Oct; 40(10):2553-2567. PubMed ID: 32432822
[TBL] [Abstract][Full Text] [Related]
37. Liver-specific deletion of the signal transducer and activator of transcription 5 gene aggravates fatty liver in response to a high-fat diet in mice.
Baik M; Nam YS; Piao MY; Kang HJ; Park SJ; Lee JH
J Nutr Biochem; 2016 Mar; 29():56-63. PubMed ID: 26895665
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of phospholipase D1 ameliorates hepatocyte steatosis and non-alcoholic fatty liver disease.
Wang H; Zhao Y; Pan Y; Yang A; Li C; Wang S; Dong Z; Li M; Wang S; Zhang Z; Zhu Y; Zhang D; Sun G
JHEP Rep; 2023 Jun; 5(6):100726. PubMed ID: 37138676
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of Hepassocin in Diabetic Patients with Nonalcoholic Fatty Liver Disease May Facilitate Increased Hepatic Lipid Accumulation.
Abdelmoemen G; Khodeir SA; Zaki AN; Kassab M; Abou-Saif S; Abd-Elsalam S
Endocr Metab Immune Disord Drug Targets; 2019; 19(2):185-188. PubMed ID: 30009716
[TBL] [Abstract][Full Text] [Related]
40. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]